A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study Evaluating the Analgesic Efficacy and Safety of Intravenous CR845 in Patients Undergoing Abdominal Surgery
Phase of Trial: Phase II/III
Latest Information Update: 11 Sep 2017
At a glance
- Drugs Difelikefalin (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Cara Therapeutics
- 06 Sep 2017 Planned End Date changed from 1 Jun 2017 to 2 Feb 2018.
- 06 Sep 2017 Planned primary completion date changed from 1 May 2017 to 29 Dec 2017.
- 03 Aug 2017 According to a Cara Therapeutics media release, completion of enrolment in this trial is expected in the fourth quarter of 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History